Compare PEN & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEN | COKE |
|---|---|---|
| Founded | 2004 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.4B |
| IPO Year | 2015 | 1994 |
| Metric | PEN | COKE |
|---|---|---|
| Price | $333.28 | $192.29 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $357.33 | N/A |
| AVG Volume (30 Days) | ★ 548.7K | 378.7K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | ★ 1155.56 | 156.81 |
| EPS | ★ 4.52 | 1.21 |
| Revenue | $1,403,665,000.00 | ★ $7,228,055,000.00 |
| Revenue This Year | $14.34 | N/A |
| Revenue Next Year | $13.71 | N/A |
| P/E Ratio | ★ $73.42 | $154.22 |
| Revenue Growth | ★ 17.50 | 4.76 |
| 52 Week Low | $221.26 | $105.21 |
| 52 Week High | $362.41 | $1,393.39 |
| Indicator | PEN | COKE |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 49.87 |
| Support Level | $326.58 | $177.28 |
| Resistance Level | $336.01 | $209.36 |
| Average True Range (ATR) | 2.27 | 6.52 |
| MACD | 0.43 | -1.10 |
| Stochastic Oscillator | 72.14 | 34.20 |
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other. Key revenue is generated from Nonalcoholic Beverages.